Post-Acute Infection Syndromes Will Be the Focus of New YSM Center
The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.
Source: yale.edu
📰 Anna Pyle News
Anna Pyle News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anna Pyle. Real-time updates on events, politics, business and more.
Antibiotics for Acne: Groundbreaking Study Shows Why One Works Best
Yale researchers, using atomic-level Cryo-EM microscopy, have discovered how and why a particular antibiotic is superior to others as a treatment for acne.
Source: yale.edu
Yale labs to lead new investigations into emerging pathogens
Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.
Source: yale.edu
Amaroq Therapeutics 'hits early milestones' in cancer treatment
NZ biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase.
Source: labiotech.eu
Alembic Pharma announces seed round investment in RIGImmune
RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic oligonucleotides
Akiko Iwasaki Anna Pyle Yale University Alembic Pharmaceuticals Vadodara Based Alembic Pharmaceuticals Alembic Pharma
Source: biospectrumindia.com
Alembic Pharma announces seed round investment in in RIGImmune
RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic oligonucleotides
Akiko Iwasaki Anna Pyle Yale University Alembic Pharmaceuticals Vadodara Based Alembic Pharmaceuticals Alembic Pharma
Source: biospectrumindia.com